Detalhe da pesquisa
1.
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM.
Proc Natl Acad Sci U S A;
116(15): 7533-7542, 2019 04 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30898885
2.
COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration.
BMC Cancer;
14: 407, 2014 Jun 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24906407
3.
Estrogen represses CXCR7 gene expression by inhibiting the recruitment of NFκB transcription factor at the CXCR7 promoter in breast cancer cells.
Biochem Biophys Res Commun;
431(4): 729-33, 2013 Feb 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23352615
4.
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations.
Cell Rep Methods;
1(5): 100084, 2021 09 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35474673
5.
Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines.
Mol Cell Endocrinol;
390(1-2): 34-44, 2014 Jun 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24721635
6.
Cyclin D1 and C/EBPß LAP1 operate in a common pathway to promote mammary epithelial cell differentiation.
Mol Cell Biol;
34(16): 3168-79, 2014 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24912680
7.
Involvement of COUP-TFs in Cancer Progression.
Cancers (Basel);
3(1): 700-15, 2011 Feb 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24212637
8.
Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.
PLoS One;
6(6): e20898, 2011.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21695171